Combination oral prednisone and intravenous immunoglobulin in the treatment of scleromyxedema

Journal of Cutaneous Medicine and Surgery

Volumn 9, Issue 3, 2005, Pages 99-104

  Majeski, Candace ^a   Taher, Muba ^a   Grewal, Parbeer ^a   Dytoc, Marlene ^a   Lauzon, Gilles ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PREDNISONE;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; GENERAL CONDITION DETERIORATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LOW DRUG DOSE; MEDICAL EXAMINATION; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SCLEROMYXEDEMA; SKIN BIOPSY; TISSUE SECTION;

AGED, 80 AND OVER; FATAL OUTCOME; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LICHENOID ERUPTIONS; MUCINOSES; PREDNISONE;

EID: 33645853200     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10227-005-0137-9     Document Type: Article

References (57)

1. HA Gottron 1954 Skleromyxodem (Eine eigenartige Erscheinungsform von Myxothesaurodermie) Arch Dermatol Syphilol 199 71
2. W Dubreuilh 1906 Fibromes miliaires folliculaires: sclerodermie consecutive Ann Dermatol Syph 37 569 572
3. K Reitmann 1908 Uber eine eigenartige, der sklerodermie nahestehende affektion Arch Dermatol Syph 92 417 424
4. S Caradonna H Jacobe 2004 Thalidomide as a potential treatment for scleromyxedema Arch Dermatol 140 277 280
5. JJ Pomann EJ Rudner 2003 Scleromyxedema revisited Int J Dermatol 42 31 35
6. AM Dinneen CH Dicken 1995 Scleromyxedema J Am Acad Dermatol 33 37 43
7. RK Lister S Jolles S Whittaker 2000 Scleromyxedema: Response to high-dose intravenous immunoglobulin (hdIVIg) J Am Acad Dermatol 43 403 408
8. A Karim MM Black F Lawlor 2003 Case 5: extensive skin eruption causing skin to become tight, sore, and itchy. Diagnosis: scleromyxoedema Clin Exp Dermatol 28 343 344
9. M Penmetcha AS Highet JM Hopkinson 1987 Failure of PUVA in lichen myxedematosus: acceleration of associated multiple keratoacanthomas with development of squamous cell carcinoma Clin Exp Dermatol 12 220 223
10. RA Harper J Rispler 1978 Lichen myxedematous serum stimulates human skin fibroblast proliferation science 188 545
11. M Yaron I Yaron I Yust 1985 Lichen myxedematosus (scleromyxedema) serum stimulates hyaluronic acid and prostaglandin E production by human fibroblasts J Rheumatol 12 171 175
12. SM Howsden JH Herndon RG Freeman 1975 Lichen myxedematosus: Dermal infiltrative disorder response to cyclophosphamide therapy Arch Dermatol 111 1325 1330
13. A Lai RFM Fat D Suurmond 1973 Scleromyxedema (lichen myxedematous) associated with a paraprotein IgG of type Kappa Br J Dermatol 88 107 116
14. S Jablonska 1975 Scleroderma and Pseudosclerderma 2 Polish Medical Publishers Warsaw 407 411
15. R Fleischmajer 2003 Papular mucinosis IM Freedberg AZ Eisen K Wolff Fitzpatrick's Dermatology in General Medicine 6 McGraw-Hill New York 1803 1805
16. A Kulczycki M Nelson A Eisen 2003 Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin Br J Dermatol 149 1276 1281
17. S Brenner I. Yust 1984 Treatment of scleromyxedema with etretinate J Am Acad Dermatol 10 295 296
18. CP Milam LE Cohen NA Fenske 1988 Scleromyxedema: therapeutic response to isotretinoin in three patients J Am Acad Dermatol 19 469 477
19. BM Hisler LB Savoy K Hashimoto 1988 Improvement of scleromyxedema associated with isotretinoin therapy J Am Acad Dermatol 19 854 857
20. KB Horn MA Horn J Swan 2004 A complete and durable clinical response to high-dose dexamethasone in a patient with Scleromyxedema J Am Acad Dermatol 51 S120 S123
21. JA Tschen JR Chang 1999 Scleromyxedema: treatment with interferon alfa J Am Acad Dermatol 40 303 307
22. LS Davis S Sanal OP Sangueza 1996 Treatment of Scleromyxedema with 2-chlorodeoxyadenosine J Am Acad Dermatol 35 288 290
23. AM Cohen E Hodar M David 1996 Beneficial effect of granulocyte-colony stimulating factor in Scleromyxedema associated with severe idiopathic neutropenia Br J Dermatol 135 626 629
24. AW MacFarlane A Davenport JL Verbov 1987 Scleromyxoedema: successful treatment with plasma exchange and immunosuppression Br J Dermatol 117 653 657
25. AI Westheim DP Lookingbill 1987 Plasmapheresis in a patient with Scleromyxedema Arch Dermatol 123 786 789
26. D Kaufman AP Truha HH Roenigk Jr 1987 Scleromyxedema: systemic manifestations and cosmetic improvement with dermabrasion Cutis 39 321 324
27. NJ Lowe PA Dufton RD Hunter 1982 Electron-beam treatment of scleromyxoedema Br J Dermatol 106 449 453
28. M Berkson GS Lazarus M Uberti-Benz 1991 Extracorporeal photochemotherapy: a potentially useful treatment for Scleromyxedema J Am Acad Dermatol 25 724
29. PM Farr FA Ive 1984 PUVA- treatment of scleromyxoedema Br J Dermatol 110 347 350
30. P Feldman L Shapiro AI Pick 1969 Scleromyxedema: a dramatic response to melphalan Arch Dermatol 99 51 56
31. RB Harris HO Perry RA Kyle 1979 Treatment of scleromyxedema with melphalan Arch Dermatol 115 295 299
32. K Schubert A Stein M Meurer 2002 Initial scleromyxedema. Successful treatment with melphalan Hautarzt 53 478 482
33. RT Jessen M Straight LE Becker 1978 Lichen myxedematosus: treatment with cyclophosphamide Int J Dermatol 17 833 839
34. I Krajnc 1997 Arndt-Gottron scleromyxedema: Summary of 2 years treatment Wien Klin Wochenschr 109 960 963
35. Z Bata-Csorgo S Husz M Foldes 1999 Scleromyxedema J Am Acad Dermatol 41 343 346
36. S Saigoh A Tashiro S Fujita 2003 Successful treatment of intractable scleromyxedema with cyclosporin A Dermatology 207 410 411
37. MA Verity J Toop LP McAdam 1978 Scleromyxedema myopathy: histochemical and electron microscopic observations Am J Clin Pathol 69 446 451
38. LP McAdam CM Pearson WH Pitts 1977 Papular mucinosis with myopathy, arthritis, and eosinophilia: a histopathologic study Arthritis Rheum 20 989 996
39. JM Wieder KL Barton JM Baron 1993 Lichen myxedematosus treated with chlorambucil J Dermatol Surg Oncol 19 475 476
40. D Rayson JA Lust A Duncan 1999 Scleromyxedema: A complete response to prednisone Mayo Clin Proc 74 481 484
41. A Righi F Schiavon S Jablonska 2002 Intravenous immunoglobulins control scleromyxoedema (Concise report) Ann Rheum Dis 61 59 61
42. A Karim F Lawlor MM Black 2004 Successful treatment of scleromyxoedema with high-dose intravenous immunoglobulin Clin Exp Dermatol 29 317 318
43. WAC Sewell S Jolles 2002 Immunomodulatory action of intravenous immunoglobulin Immunology 107 387 393
44. C Ibanez JB Montoro-Rosano 2003 Intravenous immunoglobulin preparations and autoimmune disorders: mechanism of action, Curr Pharm Biotechnol 4 239 247
45. HU Simon PJ Späth 2003 IVIG - mechanisms of action Allergy 58 543 552
46. P Imbach A Morell 1989 Idiopathic thrombocytopenic purpura (ITP): immunomodulation by intravenous immunoglobulin (IVIg) Int Rev Immunol 5 181 188
47. JW Newburger M Takahashi JC Burns 1986 The treatment of Kawasaki syndrome with intravenous gamma globulin N Engl J Med 315 341 347
48. N Sato T Sugimura T Akagi 1999 Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost-effectiveness Pediatr Int 41 1 7
49. RA Sater A Rostami 1998 Treatment of Guillain-Barre syndrome with intravenous immunoglobulin Neurology 51 S9 15
50. AF Hahn 1998 Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin Neurology 51 S16 21
51. JP Azulay O Blin J Pouget 1994 Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study Neurology 44 429 432
52. S Jolles J Hughes S Whittaker 1998 Dermatological uses of high-dose intravenous immunoglobulin Arch Dermatol 134 80 86
53. S Jolles 2002 High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders Clin Exp Immunol 129 385 389
54. C Prins C Vittorio RS Padilla 2003 Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: a retrospective, multicenter study Dermatology 207 96 99
55. MM Kozel RA Sabroe 2004 Chronic urticaria: aetiology, management and current and future treatment options Drugs 64 2515 2536
56. N Kumar M Rodriguez 2004 Scleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on interferon beta-la Mult Scler 10 85 86
57. K Amemiya C Semino-Mora RP Granger 2000 Downregulation of TGF-betal mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin Clin Immunol 94 99 104